活跃的Helicobacter pylori感染不会影响袖子胃切除术后的结果 - 观察性队列研究
Martyna Łukasiewicz1, Patryk Lisovski1, Monika Proczko-Stepaniak1
1Department of Oncological, Transplant and General Surgery, Faculty of Medicine, Medical University of Gdansk, 80-214 Gdansk, Poland.
Journal of clinical medicine
|January 11, 2025
概括
活跃的Helicobacter pylori (HP) 感染没有影响1年体重减轻或减肥手术后的并发症. 然而,HP可能会稍微减缓最初的体重减轻,这表明根除的潜在好处.
科学领域:
- 腹部外科 腹部外科
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
背景情况:
- 目前正在研究Helicobacter pylori (HP) 感染对术后并发症的影响.
- 之前的研究由于跟踪时间短暂或不完整,导致结果不确定的结果.
研究的目的:
- 为了比较袖子胃切除术 (SG) 患者的1年结果,有和没有活跃的HP感染.
- 为了评估手术后的GS标本中HP的患病率.
主要方法:
- 从93名符合条件的SG患者收集回顾性和前性数据 (2020年5月至2021年5月).
- 对人口统计数据,手术结果,并发症和体重/BMI在SG后3,6和12个月的分析.
主要成果:
- 在HP阳性和HP阴性组之间,3个月,6个月或12个月的体重减轻没有显著差异.
- 两组都实现了显著的体重减轻,HP负组显示出更大的初始减轻.
- 没有观察到与手术相关的副作用的显著差异.
结论:
- 活跃的HP感染在SG后没有影响整体1年体重减轻或并发症率.
- 在手术后的前三个月,HP感染可能会稍微延迟最初的体重减轻.
- 考虑HP根除是合理的,与潜在副作用的意识相平衡.
相关概念视频
Peptic Ulcer Disease V: Surgical Management and Nursing Care
224
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
224
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
325
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
325
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
88
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
88
Peptic Ulcer Disease I: Introduction
131
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
131
Peptic Ulcer Disease IV: Management
72
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
72
Gastritis III: Clinical Manifestations and Management
150
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
150


